Funding Rounds
Augustine Therapeutics

Augustine Therapeutics Series A (2024, $18M)

Augustine Therapeutics

Developer of therapies for neurodegenerative and cardiometabolic diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $18.20M

Investors